top of page

Management of chronic kidney disease and heart disease is changing rapidly

2in7_dark.png

WIDE IMPACT

Kidney disease and/or

heart disease affects 2 in 7

HUGE ECONOMICS

$2B every week spent by US Medicare alone

Value

TRANSITION TO VALUE-BASED CARE

Improved outcomes; reduced cost of care

In kidney disease or heart failure, important blood markers like potassium, magnesium and calcium are currently only tested in clinical settings

Reliance on venous blood testing makes it impossible to use real-time data to personalised treatments

Nurse home visit

Personalised monitoring is currently impossible

We're making active monitoring possible

Simple and easy to use by patients or clinicians

 

Rapid and minimally invasive - no more delayed results

 

Accurate self-testing for a new standard of care

_PAH8169.jpg
bottom of page